Journal: Molecular medicine reports

Article Title: Interleukin-33-induced immune tolerance is associated with the imbalance of memory and na•ve T-lymphocyte subsets.

PMID/MRN: 27748878

Publication Date: 2016-Nov-26

Abstract:

The current study aimed to investigate the distribution of memory and na•ve TĘcell (TN) subsets in hepatitisĘB virus (HBV)-infected patients at different immune stages and investigate the effect of interleukinĘ33 (IL-33) on the regulation of the T-cell subsets. The distributions of memory and na•ve T cells were detected by flow cytometry. ELISA was conducted to assess the levels of IL-4, IL-5, IL-10, IL-12, interferonĘ? and tumor necrosis factorĘ?. The expression levels of IL-33 and HBVĘx protein (HBx) were measured by reverse transcription-quantitative polymerase chain reaction and western blot analysis, respectively. By detecting TNs, central memory TĘcells (TCM) and effector memory TĘcells (TEM), it was identified that the proportions of TCM and TEM in CD4+ TĘcells were increased in patients with HBV. The trend observed for levels of CD8+ TCM and TEM was similar to that of CD4+ T cells in the immune tolerance and immune activation groups, however CD8+ TCM and TEM were significantly reduced in patients who underwent treatment. The CD8+ TEM cells appeared to be more sensitive to HBV activation and drug therapy. In addition, IL-33 stimulation was observed to induce imbalances of CD8+ TN and CD8+ TEM, and while the imbalances were directly regulated by HBx, IL-33 was not a key factor for the expression of HBx. CD8+ TEM cells may be a sensitive marker to assess the immune state of patients with HBV and the effect of clinical therapy. Treatment targeting IL-33 may be a potential method to reverse HBV-induced immune tolerance.